静脉导管市场按产品类型、材料、最终用户和地区划分（2024-2031 年）

静脉导管市场评估 - 2024-2031

人们对自我护理和家庭医疗保健的日益关注，推动了对方便患者在临床环境外使用的静脉导管的需求。随着越来越多的患者选择在家中进行护理和自行用药，对方便在非临床环境中使用的静脉导管的需求也日益增长。因此，自我护理和家庭医疗保健的成长推动了市场规模在2024年超过89.2亿美元，到2031年将达到174.9亿美元。

医院和门诊手术中心手术数量的增加促进了市场扩张。输液导管在手术期间和术后的液体、药物和营养支持中发挥着至关重要的作用，增加了手术全期和术后护理的需求。外科手术数量的增加推动了对各种静脉导管产品的需求，以支援整个手术过程中的病患照护。因此，预计外科手术数量的增加将推动市场在2024年至2031年间以8.78%的复合年增长率成长。

静脉导管市场：定义/概述

静脉 (IV) 导管是一种细长、柔软的管子，插入静脉后可直接将液体、药物和血液製品输送到血液中。它们是必不可少的医疗器械，广泛应用于医院、诊所和居家照护等各种医疗机构，医疗设备。

静脉导管提供了一种直接有效的治疗物质输送途径，无需经过消化器官系统。这种方法对于那些无法经口进食或饮水，以及需要快速给药的患者尤其有利。静脉导管将药物和营养物质直接输送到血液中，从而实现精准、即时的治疗效果，这对于控制急性症状和支持持续治疗至关重要。

除了在医院和临床环境中使用外，静脉导管也越来越多地应用于家庭护理，为需要持续或间歇性治疗的患者提供必要的支持。多功能且高效的静脉治疗是现代医学的基石，有助于全面患者照护，并改善各种医疗环境中的治疗效果。

医疗保健领域的快速技术进步和创新将如何推动静脉导管市场的成长？

医疗领域的快速技术进步和创新推动了静脉导管市场的成长。近期趋势包括新型週边静脉导管、中央静脉导管和中线週边导管，旨在有效地将液体和药物直接输送到患者血液中。许多此类导管涂有缓释药物，有助于缓解疼痛和消炎。

中心静脉导管市场尤其活跃，其尖端设计、材料使用和输送机制不断创新。供应商正在推出能够承受高压并与动力注射系统相容的先进针头。这些改进旨在提高患者舒适度并最大限度地降低血液感染风险，推动市场的成长。

多腔中央静脉导管(CVC) 的需求不断增长，这是一个值得关注的趋势。多腔 CVC 为需要频繁静脉输液、输血、实验室检查和肠外营养的患者提供了显着的益处。它们非常受欢迎，因为它们减少了反覆插入导管的需要，并降低了感染疾病风险。供应商越来越注重开发和提供这些多腔导管，以提高效率、增加销售量和利润率。

技术进步也包括利用奈米技术来强化导管材料。奈米级改质可提高生物相容性并降低血栓形成风险，从而降低血栓形成的风险。此外，导管上的抗菌涂层可以抑制细菌生长，降低导管相关感染的发生率。超音波技术正被用于引导导管插入，从而提高准确性、减少併发症并提高手术成功率。这些技术创新共同推动了全球中央静脉导管市场的成长，因为它们解决了关键挑战并改善了患者预后。

由于多种因素，静脉导管的需求预计将大幅成长。越来越多的监管机构核准静脉导管，从而提高了市场的可靠性和可用性。包括神经系统、心血管和泌尿系统疾病在内的慢性疾病的盛行率不断上升，推动了对这些设备的需求，尤其是在老年人口不断增长、需要更频繁的医疗干预的情况下。此外，人们越来越意识到预防和管理导管相关血流感染 (CRBSI) 的必要性，预计也将进一步推动需求。随着医护人员和患者都更加重视感染控制和提高病人安全性，预计在整个预测期内，静脉导管的使用量将会增加。

导管血流相关的感染风险将如何阻碍静脉导管市场的成长？

感染疾病风险，例如导管相关性血流感染 (CRBSI)，是一项重大挑战，促使医疗机构采用严格的通讯协定来降低风险。然而，这些措施增加了操作复杂性和整体成本，给医疗系统和製造商都带来了压力。患者不适感也是一个重大问题。插入和维持留置静脉导管会引起疼痛和不适，从而导致患者不满。这种不适感也可能导致患者拒绝治疗或停止使用，影响静脉治疗的有效性和可接受性。

产品召回也是一大风险。任何与导管品质相关的问题，例如併发症或製造缺陷，都可能导致召回。此类事件会损害製造商的声誉，削弱市场信心，进而影响销售和市场动态。成本压力使情况更加复杂。先进导管技术带来的成本上升以及持续创新的需求，可能会对製造商的定价和盈利造成巨大压力。在成本敏感的市场中，如何在价格承受能力和技术进步之间取得平衡仍然是一项挑战。

此外，监管障碍也构成了重大限制。严格的器械核准和市场准入监管要求延长了开发时间并增加了成本。满足这些法规要求需要大量的投资和资源，这可能会延迟新产品的推出并影响整体市场的成长。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第三章 市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

4. 输液导管市场（依产品类型）

• 週边静脉导管
• 中央静脉导管（CVC）
• 中线週边导管
• 整合/封闭式静脉导管

5. 静脉导管市场（依材质）

• 聚氨酯静脉导管
• 硅胶静脉导管
• 特氟龙静脉导管

6. 静脉导管市场（依最终使用者）

• 医院
• 门诊手术中心（ASC）
• 诊所
• 居家医疗

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市占率分析

第十章：公司简介

• BD（Becton, Dickinson and Company）
• B. Braun Melsungen AG
• ICU Medical, Inc.
• Teleflex Incorporated
• Terumo Corporation
• Smiths Medical
• Medtronic
• Abbott Laboratories
• Edwards Lifesciences Corporation
• Coloplast A/S
• Stryker Corporation
• Cook Medical
• Merit Medical Systems, Inc.
• Vygon
• Nipro Corporation
• Medsource Labs

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

IV (Intravascular) Catheter Market Valuation - 2024-2031

The increasing focus on self-care and home-based healthcare is driving the demand for IV catheters that are user-friendly for patients to use outside of clinical settings. As more patients manage their care and self-administer medications at home, there is a growing need for IV catheters designed for ease of use in non-clinical environments. Thus, the growth in self-care and home-based healthcare surged the growth of market size surpassing USD 8.92 Billion in 2024 to reach a valuation of USD 17.49 Billion by 2031.

The rising number of surgical procedures performed in hospitals and ambulatory surgical centers is contributing to the market's expansion. The need for IV catheters is heightened for perioperative and postoperative treatments, as they play a crucial role in administering fluids, medications, and nutrients during and after surgeries. This increase in surgical activity is driving demand for a wide range of IV catheter products to support patient care throughout the surgical process. Thus, the increasing number of surgical procedures enables the market to grow at a CAGR of 8.78% from 2024 to 2031.

IV (Intravascular) Catheter Market: Definition/ Overview

An intravenous (IV) catheter is a slender, flexible tube inserted into a vein to facilitate the direct delivery of fluids, medications, or blood products into the bloodstream. This essential medical device is widely utilized across various healthcare settings, including hospitals, clinics, and home care environments, to provide swift and effective treatment for a range of medical conditions.

IV catheters offer a direct and efficient route for administering therapeutic substances, bypassing the digestive system. This method is particularly advantageous for patients who are unable to consume food or fluids orally due to medical conditions, or when there is a need for rapid medication delivery. By ensuring that medications and nutrients are introduced directly into the bloodstream, IV catheters enable precise and immediate therapeutic effects, which is crucial for managing acute conditions and supporting ongoing treatments.

In addition to their use in hospital and clinical environments, IV catheters are increasingly employed in home care settings, where they provide vital support for patients requiring continuous or intermittent treatments. The versatility and efficiency of IV therapy make it a cornerstone of modern medical practice, facilitating comprehensive patient care and enhancing treatment outcomes across diverse healthcare scenarios.

How the Rapid Technological Advancements and Innovations in the Healthcare Sector Surge the Growth of IV Catheters Market?

Rapid technological advancements and innovations in the medical sector surge the growth of IV catheters market. Recent developments include novel peripheral IV catheters, central venous catheters, and midline peripheral catheters, which are designed to efficiently administer fluids and medications directly into the patient's bloodstream. Many of these catheters are coated with medications that are gradually released, helping to alleviate pain and reduce inflammation.

The market for central IV catheters is particularly dynamic, with ongoing innovations in tip design, material usage, and delivery mechanisms. Vendors are introducing advanced needles that can withstand high pressure and are compatible with power injectable systems. These improvements aim to enhance patient comfort and minimize the risk of bloodstream infections, driving market growth.

The rising demand for multi-lumen central venous catheters (CVCs) is a notable trend. Multi-lumen CVCs offer significant advantages for patients who require frequent intravenous medications, blood transfusions, laboratory tests, and parenteral nutrition. They reduce the need for multiple catheter insertions and lower the risk of infections, making them highly desirable. Vendors are increasingly focused on developing and offering these multi-lumen catheters to enhance efficiency and improve sales volume and profit margins.

Technological advancements also include the use of nanotechnology to enhance catheter materials. Nanoscale modifications improve biocompatibility and reduce thrombogenicity, which decreases the risk of clot formation. Additionally, integrating antimicrobial coatings on catheters helps prevent bacterial growth, reducing the incidence of catheter-related infections. Ultrasound technology is being employed to guide catheter insertion, which improves accuracy, reduces complications, and increases the success rate of procedures. These innovations collectively drive the growth of the global central IV catheter market, as they address key challenges and improve patient outcomes.

The demand for intravenous catheters is expected to rise significantly due to several factors. Increasing regulatory approvals for IV catheters are boosting market confidence and availability. The growing incidence of chronic disorders, including neurological, cardiovascular, and urological conditions, is driving the need for these devices, particularly as the elderly population continues to expand and requires more frequent medical interventions. Additionally, heightened awareness regarding the prevention and control of catheter-related bloodstream infections (CRBSI) is anticipated to further fuel demand. As both healthcare providers and patients become more focused on infection control and improving patient safety, the use of intravenous catheters is likely to increase throughout the forecast period.

How the Infection Risk Associated with the catheter bloodstream Impede the Growth of IV Catheter Market?

The risk of infection, such as catheter-related bloodstream infections (CRBSIs). These infections present significant challenges, prompting healthcare facilities to adopt stringent protocols to mitigate risks. However, these measures can increase operational complexities and overall costs, adding pressure to healthcare systems and manufacturers alike. Patient discomfort is another critical issue. The insertion and maintenance of IV catheters can cause pain and discomfort, which may lead to patient dissatisfaction. This discomfort can sometimes result in patients refusing treatment or discontinuing use, affecting the effectiveness and acceptance of IV therapy.

Product recalls pose a substantial risk as well. Any issues related to catheter quality, such as complications or manufacturing defects, can lead to recalls. Such incidents damage the reputation of manufacturers and undermine market confidence, potentially impacting sales and market dynamics. Cost pressures further complicate the landscape. The rising costs associated with advanced catheter technologies and the need for continual innovation can exert significant pressure on pricing and profitability for manufacturers. Balancing affordability with technological advancements remains a challenge in a cost-sensitive market.

Additionally, regulatory hurdles are a considerable restraint. The stringent regulatory requirements for device approval and market entry can extend development timelines and increase costs. Navigating these regulations requires substantial investment and resources, which can delay the introduction of new products and impact overall market growth.

Category-Wise Acumens

How the Low-Cost Therapy and Highly Favored Clinical Settings Surge the Growth of the Peripheral IV Catheter Segment?

The peripheral IV catheter segment significantly dominates the IV catheter market. Peripheral intravenous catheters (PIVCs) are increasingly favored in clinical settings for their ease of installation and removal, offering a more comfortable and minimally invasive option for obtaining intravenous therapy. This approach enhances patient satisfaction and proves to be more cost-effective compared to midline peripheral catheters and central venous catheters. The low cost of PIVCs, coupled with their user-friendly nature, positions them as a popular choice in various medical procedures.

The market for PIVCs is expected to experience growth driven by strategic initiatives from industry players, such as the introduction of innovative products, strategic partnerships, and mergers and acquisitions. This peripheral catheter significantly reduces the risk of needle stick injuries and blood exposure, contributing to safer intravenous access for healthcare providers.

Furthermore, the increasing preference for minimally invasive procedures is fueling the demand for PIVCs. These procedures are associated with shorter recovery times, reduced discomfort, and lower risk of complications, making them appealing for both patients and healthcare practitioners. PIVCs are commonly used to administer anesthetics and medications during such procedures, underscoring their importance in modern medical practices. As the adoption of minimally invasive techniques continues to rise, the demand for PIVCs is expected to grow, driven by their practical benefits and the ongoing evolution of medical technologies.

How do the Increasing Medical Procedures and Escalating Hospitalization Rates Foster the Growth Hospitals Pharmacies Segment?

The Hospital Pharmacies segment significantly dominates the IV Catheter Market. The global increase in hospitalization rates and the growing volume of medical procedures requiring IV fluid and solution infusion are major drivers of the IV catheter market. Hospitals remain the primary setting for IV catheter use, accounting for the majority of sales and continuing to dominate the market.

In these healthcare facilities, hospital pharmacies and stores play a crucial role in the distribution and storage of pharmaceuticals, including IV catheters. These on-site pharmacies manage a broad range of medications, from standard treatments to specialized and experimental drugs. As hospitals prioritize patient safety, there is a significant focus on minimizing the risks associated with IV catheter use, such as infections and complications.

In addition, to these concerns, hospitals are increasingly demanding IV catheters that feature advanced safety features. For instance, IV catheters with antimicrobial coatings are sought after for their ability to reduce infection risks, while needleless connectors are preferred for their role in minimizing needle-stick injuries and enhancing overall safety. This trend highlights the hospital's commitment to improving patient outcomes and safety through the adoption of more sophisticated and safer catheter technologies.

Gain Access to IV (Intravascular) Catheter Market Report Methodology

Country/Region-wise Acumens

How do the Increasing Geriatric Population and the Extensive Network of Hospitals in the Region Surge the Growth of the IV (Intravascular) Catheter Market?

North America substantially dominates the IV (Intravascular) catheter market. The increasing prevalence of chronic disorders and the rising geriatric population contribute to a higher demand for IV catheters, driven further by the presence of leading manufacturers such as Boston Scientific Corporation, BD, and Teleflex Incorporated. These companies are positively impacting regional market growth through their innovations and market activities. The extensive network of hospitals, clinics, and ambulatory care centers worldwide creates a substantial and consistent demand for IV catheters. The broad availability of these healthcare facilities ensures that a large patient base, requiring intravenous treatments for various conditions, has reliable access to essential catheter devices. The increasing global elderly population is particularly susceptible to chronic diseases that often necessitate prolonged or frequent IV therapy. As the number of aging individuals rises, so does the need for IV catheters to manage age-related health issues effectively and provide ongoing medical care.

Favorable government policies, heightened public awareness, and the presence of highly qualified medical professionals and renowned healthcare facilities further bolster the market's expansion in North America. The high incidence of chronic diseases is anticipated to increase hospital admissions, which in turn will drive demand for vascular catheterization and vein access treatments. Innovations such as advanced biocompatible materials, antimicrobial coatings, and user-friendly designs are improving patient outcomes and driving market growth. These advancements contribute to safer, more effective catheterization processes, benefiting patients and healthcare providers.

Additionally, strategic initiatives by market players, including product innovations and various other activities, are contributing to the region's market growth. North America is expected to hold the largest share of the intravascular catheters market during the forecast period, largely due to the increasing incidence of renal diseases. The increasing emphasis on reducing healthcare-associated infections (HAIs) and improving patient safety. This focus has led to the development and adoption of advanced IV catheters equipped with features such as needleless connectors and antimicrobial coatings. Stringent regulations and guidelines surrounding infection control are propelling the market for these advanced safety-oriented products.

How the Increasing Investments in the Healthcare Sector and Growing Incidence of Chronic Conditions Foster the Growth of IV (Intravascular) Catheter Market?Bottom of Form

Investments in expanding and upgrading healthcare facilities fueling strong demand for medical devices, including IV catheters. The establishment of new hospitals, clinics, and specialized care centers, along with the enhancement of existing infrastructure, ensures that a wide array of medical devices, including IV catheters, are required to support advanced patient care. The growing incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is driving a heightened need for long-term IV therapy. As these diseases become more prevalent, the demand for IV catheters increases, given their essential role in the ongoing management and treatment of these conditions. In countries like Japan and South Korea, the rapidly aging population is leading to a greater need for IV catheters. Older adults are more prone to chronic illnesses and age-related health issues that often require intravenous treatment. This demographic shift is substantially driving the demand for IV catheters to address the specific needs of the elderly.

Increasing disposable incomes are enhancing access to healthcare services and advanced medical treatments. As individuals' financial capabilities improve, they are more likely to seek high-quality medical care and invest in advanced medical technologies, including IV catheters. This rise in disposable income contributing to the broader adoption of these medical devices. Government support for healthcare infrastructure development and a strong emphasis on patient safety are pivotal in driving market growth. Various government initiatives aim to improve healthcare access, implement rigorous infection control measures, and promote the use of advanced medical devices. These efforts are supporting the expansion of the IV catheter market by fostering a safer and more efficient healthcare environment.

Competitive Landscape

The IV (Intravascular) catheter market is characterized by a mix of established global players and regional manufacturers. The industry is highly competitive, with companies focused on product innovation, cost-efficiency, and strong distribution networks.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the IV (Intravascular) catheter market include:

• BD (Becton, Dickinson, and Company)
• Braun Melsungen AG
• ICU Medical, Inc.
• Teleflex Incorporated
• Terumo Corporation
• Smiths Medical
• Medtronic
• Abbott Laboratories
• Edwards Lifesciences Corporation
• Coloplast A/S
• Stryker Corporation
• Cook Medical
• Merit Medical Systems, Inc.
• Vygon
• Nipro Corporation
• Medsource Labs

Latest Developments:

• In October 2023, Linear Health Sciences announced that the Orchid SRV safety release valve had achieved US FDA approval. The device was approved for use with all IV access procedures; the catheter was designed to reduce the likelihood of IV catheter failure and repair in hospitals.
• In April 2023, BD announced the Prevue II System, a completely innovative, user-friendly sophisticated ultrasound system with a tailored probe designed to assist surgeons in accurately implanting intravenous placements.
• In September 2022, B. Braun SE announced the acquisition of Starboard Medical, Inc.'s cutting-edge Clik-FIX catheter protection device portfolio. With this acquisition, B. Braun added to its track record of creating new products and programs that improve patient outcomes and experiences with peripheral intravenous (IV) therapy.
• In January 2022, ICU Medical, Inc. Smiths Medical announced the acquisition of Smiths Group plc. Smith's Medical specializes in syringe and mobile infusion devices, vascular access, and critical care solutions.

IV (Intravascular) Catheter Market, By Category

• Product Type:
• Peripheral IV Catheters
• Central Venous Catheters (CVCs)
• Midline Peripheral Catheters
• Integrated/Closed IV Catheters
• Material:
• Polyurethane IV Catheter
• Silicone IV Catheters
• Teflon IV Catheters
• End-User:
• Hospitals Pharmacies
• Retail Pharmacies
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Iv Catheters Market, By Product Type

• Peripheral IV Catheters
• Central Venous Catheters (CVCs)
• Midline Peripheral Catheters
• Integrated/Closed IV Catheters

5. Iv Catheters Market, By Material

• Polyurethane IV Catheters
• Silicone IV Catheters
• Teflon IV Catheters

6. Iv Catheters Market, By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Clinics
• Homecare Settings

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• BD (Becton, Dickinson and Company)
• B. Braun Melsungen AG
• ICU Medical, Inc.
• Teleflex Incorporated
• Terumo Corporation
• Smiths Medical
• Medtronic
• Abbott Laboratories
• Edwards Lifesciences Corporation
• Coloplast A/S
• Stryker Corporation
• Cook Medical
• Merit Medical Systems, Inc.
• Vygon
• Nipro Corporation
• Medsource Labs

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References